Synaptogenix Inc has a consensus price target of $0, established from looking at the 2 latest analyst ratings. The last 2 analyst ratings were released from Maxim Group and Maxim Group on December 19, 2022 and April 12, 2022. With an average price target of $7 between Maxim Group and Maxim Group, there's an implied 59.09% upside for Synaptogenix Inc from these 2 analyst ratings.
1calculated from analyst ratings published within the last 3 years
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|
12/19/2022 | SNPX | Buy Now | Synaptogenix | $4.40 | — | Maxim Group | Jason McCarthy | — | Downgrade | Buy → Hold | Get Alert |
04/12/2022 | SNPX | Buy Now | Synaptogenix | $4.40 | 218.18% | Maxim Group | Jason McCarthy | → $350 | Initiates | → Buy | Get Alert |
The latest price target for Synaptogenix (NASDAQ: SNPX) was reported by Maxim Group on December 19, 2022. The analyst firm set a price target for $0.00 expecting SNPX to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.
The latest analyst rating for Synaptogenix (NASDAQ: SNPX) was provided by Maxim Group, and Synaptogenix downgraded their hold rating.
There is no last upgrade for Synaptogenix.
The last downgrade for Synaptogenix Inc happened on December 19, 2022 when Maxim Group changed their price target from N/A to N/A for Synaptogenix Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Synaptogenix, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Synaptogenix was filed on December 19, 2022 so you should expect the next rating to be made available sometime around December 19, 2023.
While ratings are subjective and will change, the latest Synaptogenix (SNPX) rating was a downgraded with a price target of $0.00 to $0.00. The current price Synaptogenix (SNPX) is trading at is $4.40, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.